Genotyping Analytik Jena Signs Co-Marketing Agreement with Illumina
Analytik Jena has entered a partnership with Illumina, headquartered in San Diego, which allows the company to gains access to the growing genotyping market currently being served by Illumina’s technologies.
Jena /Germany — The German company provides a production scale solution for ultra-high throughput sample preparation in support of Illumina’s enhanced 96-sample Infinium XT Bead Chip.
The agreement is structured as a co-development and co-marketing partnership to provide a turnkey automated sample preparation solution for the Infinium XT UHT protocols which allow for ultra-high throughput genotyping, scaling from several hundred thousand to 1 million samples per year.
“This partnership further strengthens Analytik Jena’s presence in the genomics market,” said Ulrich Krauss, CEO of Analytik Jena. “We look forward to working with Illumina and their customers to deploy solutions for ultra-high throughput genotyping.”